Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of the American Chemical Society|November 26, 2004
Ligand-switchable directing effects of tethered alkenes in nickel-catalyzed additions to alkynesKaren M Miller, Timothy F JamisonOrganic Letters|July 1, 2005
Highly regioselective, catalytic asymmetric reductive coupling of 1,3-enynes and ketonesKaren M Miller, Timothy F JamisonJournal of the American Chemical Society|March 20, 2003
Catalytic asymmetric reductive coupling of alkynes and aldehydes: enantioselective synthesis of allylic alcohols and alpha-hydroxy ketonesKaren M Miller, Wei-Sheng Huang, Timothy F JamisonJournal of the American Chemical Society|April 1, 2004
Alkene-directed, nickel-catalyzed alkyne coupling reactionsKaren M Miller, Torsak Luanphaisarnnont, Carmela Molinaro, et al.Paediatric Anaesthesia|March 15, 2016
Etiology of postanesthetic and postsedation events on the inpatient ward: data from a rapid response team at a tertiary care children's hospitalN'Diris Barry, Karen M Miller, Gregory Ryshen, et al.Paediatric Anaesthesia|June 5, 2015
Long-term tolerability of capnography and respiratory inductance plethysmography for respiratory monitoring in pediatric patients treated with patient-controlled analgesiaKaren M Miller, Andrew Y Kim, Myron Yaster, et al.Journal of Neurochemistry|June 11, 2004
Reduction of excitotoxicity and associated leukocyte recruitment by a broad-spectrum matrix metalloproteinase inhibitorSandra J Campbell, Malcolm Finlay, John M Clements, et al.Clinical Transplantation|July 11, 2021
Discrepant subtyping of blood type A2 living kidney donors: Missed opportunities in kidney transplantationNeetika Garg, Leza Warnke, Robert R Redfield, et al.Nature Medicine|February 26, 2004
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivoElizabeth A Harrington, David Bebbington, Jeff Moore, et al.Kidney International|March 1, 2013
Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipientsArjang Djamali, Brenda L Muth, Thomas M Ellis, et al.Pageof 1